Welcome to LookChem.com Sign In|Join Free
  • or
N,N-dimethyl-2-(1-benzyl-1H-indol-3-yloxy)ethanamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

702703-07-9

Post Buying Request

702703-07-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

702703-07-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 702703-07-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,2,7,0 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 702703-07:
(8*7)+(7*0)+(6*2)+(5*7)+(4*0)+(3*3)+(2*0)+(1*7)=119
119 % 10 = 9
So 702703-07-9 is a valid CAS Registry Number.

702703-07-9Downstream Products

702703-07-9Relevant academic research and scientific papers

Palladium-catalyzed direct and regioselective C-H bond functionalization/ oxidative acetoxylation of indoles

Choy, Pui Ying,Lau, Chak Po,Kwong, Fuk Yee

, p. 80 - 84 (2011/03/22)

The first general examples of palladium-catalyzed direct and selective oxidative C3-acetoxylation of indoles are presented. The mild reaction conditions (70 °C and with weak base, KOAc) in this indole C-H-acetoxylation are notable.

N-ARYLALKYL-3-AMINOALKOXYINDOLES AND THEIR USE AS 5-HT LIGANDS

-

Page 53, (2010/02/07)

The present invention describes substituted 3-Aminoalkoxyindoles, as compounds of the general formula (I), its stereoisomers, its radioisotopes, its geometric forms, its N-oxides, its polymorphs, its pharmaceutically acceptable salts, its pharmaceutically acceptable solvates, its useful bioactive metabolites and any suitable combination of the above. The invention also discloses the processes for preparing such compounds of the general formula (I), its stereoisomers, its radioisotopes, its geometric forms, its N-oxides, its polymorphs, its pharmaceutically acceptable salts, its pharmaceutically acceptable solvates, its useful bio-active metabolites and also includes any suitable combination of the above. Further described are various methods of administering these compounds of general formula (I), i.e. pharmaceutically acceptable dosage forms, their composition and their use in either therapy or diagnosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 702703-07-9